UTICA — The Masonic Medical Research Institute (MMRI) in Utica will use a $500,000 grant from the U.S. Department of Defense (DOD) for an ongoing research project. It directly addresses a critical need for military personnel who have survived catastrophic injuries, particularly those from blasts, MMRI said. The money will aid the work in developing […]
Already an Subcriber? Log in
Get Instant Access to This Article
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
- Critical Central New York business news and analysis updated daily.
- Immediate access to all subscriber-only content on our website.
- Get a year's worth of the Print Edition of The Central New York Business Journal.
- Special Feature Publications such as the Book of Lists and Revitalize Greater Binghamton, Mohawk Valley, and Syracuse Magazines
Click here to purchase a paywall bypass link for this article.
UTICA — The Masonic Medical Research Institute (MMRI) in Utica will use a $500,000 grant from the U.S. Department of Defense (DOD) for an ongoing research project.
It directly addresses a critical need for military personnel who have survived catastrophic injuries, particularly those from blasts, MMRI said.
The money will aid the work in developing methods to examine the health of vascularized composite allografts (VCA).
This will result in doctors having the ability to quickly determine whether graft rejection is occurring and alter the immunosuppression needed to keep the transplant viable, MMRI said.
VCAs are transplants made of skin, muscle, bones, and nerves, such as an arm or a face, to restore function and appearance.
Those surviving blasts would be candidates for VCAs, yet the risks associated with this “life-changing” therapeutic option “often outweigh the benefits,” as rejection of the graft could put the patient’s life at risk.
Jason McCarthy, associate professor of biomedical research and translational medicine at MMRI, is the principal investigator.
“Our goal is to develop technologies to facilitate routine examination of markers of rejection to catch episodes early, allowing for the modification of immunosuppressive therapies,” McCarthy said in the MMRI announcement. “Current gold standard diagnostics detect rejection too late. Using our technology, we envision in-home monitoring of graft health, enabling more widespread adoption of VCA transplantation.”
McCarthy — working alongside Carl Atkinson, Ph.D., from Northwestern University — combines expertise in the immune system with bioengineering to design these advanced imaging tools. The ultimate vision is to make these tools available in simple, user-friendly devices, MMRI said.
“We’re conducting groundbreaking research right here in the Mohawk Valley,” Maria Kontaridis, Ph.D., executive director, Gordon K. Moe professor and chair of biomedical research and translational medicine at MMRI, contended. “This funding will empower our talented scientists to help a part of the population who have sacrificed so much to keep our country safe — our dedicated soldiers and veterans. I am incredibly proud of Dr. McCarthy and his team for leading this vital project.”
The nonprofit MMRI says it is dedicated to scientific research that improves the health and quality of life for all humankind.
“We conduct high quality research aimed at developing a deeper understanding of the causes of cardiovascular, neurocognitive and autoimmune diseases, in the hopes of identifying innovative treatments and cures for these devastating ailments,” per the announcement.


